The biologic mechanisms underlying the potentially differing susceptibility to infection by ABO blood group may stem directly from the ABO blood group and the development of neutralizing antibodies against protein-linked N-glycans, for example, [40], or, indirectly, from other mediated effects that could include the stabilization of von Willebrand factor [41–45]. This evidence concerns the gene VWF and infection.